Reasons for not commencing direct-acting antiviral treatment despite unrestricted access for individuals with HIV and hepatitis C virus: a multinational, prospective cohort study.
Isfordink CJ, Boyd A, Sacks-Davis R, van Santen DK, Smit C, Martinello M, Stoove M, Berenguer J, Wittkop L, Klein MB, Rauch A, Salmon D, Lacombe K, Stewart A, Schinkel J, Doyle JS, Hellard M, van der Valk M, Matthews GV; InCHEHC study group.
Isfordink CJ, et al.
Lancet Public Health. 2023 Apr;8(4):e294-e304. doi: 10.1016/S2468-2667(23)00056-7.
Lancet Public Health. 2023.
PMID: 36965984
Free article.